ASLAN Pharmaceuticals Pte.

PharmaceuticalsSeries CSingapore, Singaporeaslanpharma.com

Latest round

Series C

Last raised

Jan 2016

Total raised

$77M

Investors

8

About ASLAN Pharmaceuticals Pte.

Founded in 2010, chaired by Carl Firth as CEO, and based in Singapore, ASLAN Pharmaceuticals Pte. Ltd is a clinical-stage immunology-focused biopharmaceutical company developing treatments and therapies focused on atopic dermatitis, and other immunology indications and autoimmune diseases. The company operates across Taiwan, China, and Australia. The company trades on NASDAQ under the ticker symbol ASLN. ASLAN004 is in Phase 1 of the clinical trials. Additionally, the company’s pipeline includes ASLAN003, an oral inhibitor of DHODH in the development of autoimmune diseases such as Dengue and Zika viruses. The company is currently assessing the potential of ASLAN003 as a treatment for Covid-19. As of 2021, the company has an AhR antagonist, a druggable transcription factor that acts as a master regulator of the immune system, in the discovery stage for oncology. The company plans to begin the Phase 2b study of ASLAN004 in the second half of 2021 and to roll out its cancer drug in China, the US, and Europe in the future.

Who invested in ASLAN Pharmaceuticals Pte.

8 investors across 4 rounds

See all investors in ASLAN Pharmaceuticals Pte.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 7, 2016

    Amount

    $9M

    Investors

    Locked

  2. Series C

    Dec 7, 2015

    Amount

    $34M

    Investors

    Locked

  3. Series B

    Oct 10, 2013

    Amount

    $22M

    Investors

    Locked

  4. Series A

    Jul 1, 2011

    Amount

    $12M

    Investors

    Locked

Questions about ASLAN Pharmaceuticals Pte.

Who invested in ASLAN Pharmaceuticals Pte.?

ASLAN Pharmaceuticals Pte. has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ASLAN Pharmaceuticals Pte. raised?

ASLAN Pharmaceuticals Pte. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did ASLAN Pharmaceuticals Pte. last raise money?

ASLAN Pharmaceuticals Pte.'s most recent round on record is a Series C, in Jan 2016.

What does ASLAN Pharmaceuticals Pte. do?

Founded in 2010, chaired by Carl Firth as CEO, and based in Singapore, ASLAN Pharmaceuticals Pte.

Where is ASLAN Pharmaceuticals Pte. headquartered?

ASLAN Pharmaceuticals Pte. is headquartered in Singapore, Singapore.

Which VCs invest in companies like ASLAN Pharmaceuticals Pte.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at ASLAN Pharmaceuticals Pte.'s stage. Their profiles are linked below.

Raising like ASLAN Pharmaceuticals Pte.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.